Home›Stock Screener›Glen Industries

Glen Industries Share Price Today | Stock Price & Glen Industries Share Screener

GLEN Pharmaceuticals

Track the current Glen Industries share price and stock price live with TickJournal's free stock screener. Check GLEN annual price range for the annual price range and momentum. Use the Glen Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Glen Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Glen Industries Market Cap ₹306.56 Cr.
GLEN P/E Ratio (TTM) -
Glen Industries P/B Ratio 2.22
EPS (TTM) ₹6.86
Dividend Yield -
Debt to Equity 1.28
GLEN 52 Week High -
Glen Industries 52 Week Low -
Operating Margin -
Profit Margin -
GLEN Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹291.00
Total Equity ₹140.00

Glen Industries Share Price Chart

Track the current stock price of Glen Industries with an interactive chart. Analyse GLEN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Glen Industries stock quote in one place.

Glen Industries Company Profile - Fundamental Screener

Screen Glen Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GLEN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0UMC01019.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0UMC01019

Glen Industries Balance Sheet Screener

Screen GLEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹291, up from ₹214 in 2025.

Latest statistics put total assets at ₹291 and shareholder funds at ₹140, with a leverage ratio of 1.28.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 291 214 161 137 116
Current Assets 169 104 78 62 58
Fixed Assets 109 108 81 73 55

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 30 56 40 41 41
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 140 59 46 36 23
Share Capital 32 18 6 6 6
Reserves & Surplus 107 41 40 31 17

Glen Industries Income Statement Screener - Profit & Revenue Analysis

Screen Glen Industries income statement and profit fundamentals. Analyze GLEN quarterly results. Glen Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹205 and net profit of ₹17.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March

Revenue and Expenses

Revenue 0 205 171 145 120 97
Expenses 0 166 130 120 103 83

Operating Costs and Margins

EBITDA 0 39 41 25 17 14
Operating Profit % 0.00% 18.00% 24.00% 17.00% 14.00% 12.00%
Depreciation 0 8 7 6 6 5
Interest 0 9 9 7 6 4

Profit and Earnings

Profit Before Tax 0 22 24 11 3 5
Tax 0 5 6 3 1 1
Net Profit 0 17 18 9 2 4
EPS 0.00 6.86 10.39 82.42 0.85 2.09

Glen Industries Cash Flow Screener - Liquidity Fundamentals

Screen GLEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹6, and net cash flow was an outflow of ₹1.

Over the same period, investing activities used ₹18 and financing activities provided ₹11.

Item 2026-March 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities 6 6 14 11 -14
Investing Activities -18 -35 -13 -15 -22

Financing and Net Cash

Financing Activities 11 30 -2 4 34
Net Cash Flow -1 1 -1 0 -2

Glen Industries Shareholding Pattern Screener

See Glen Industries shareholding pattern with promoter, FII, and DII holdings. Check Glen Industries promoter holding and ownership changes for GLEN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 73.31%, foreign institutions 0.00%, domestic institutions 6.64% and the public 15.47%, spread across 1,118 shareholders.

The shareholder count was 1,118 in 2026-Mar, compared with 1,267 in 2025-Jun.

Item 2026-Mar 2025-Jun 2025-Jul 2025-Sept 2024-Dec

Promoter Holding

Promoter Holding 73.31% 73.00% 73.00% 73.00% 100.00%

Institutional Investors

FII Holding 0.00% 1.83% 1.83% 0.22% 0.00%
DII Holding 6.64% 9.93% 9.93% 9.06% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 15.47% 11.95% 11.95% 12.31% 0.00%
Other Holding 4.57% 3.29% 3.29% 5.41% 0.00%
Shareholder Count 1,118 1,267 7 1,196 7

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Glen Industries. Glen Industries dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Glen Industries.

Glen Industries Stock Index Membership - Nifty & Sensex

See which indices include Glen Industries stock. Check GLEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Glen Industries is not part of any tracked indices.
Only major market indices are tracked in our system.

Glen Industries Market Events Screener - Corporate Actions

Get Glen Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Glen Industries stock events that may affect GLEN share price, along with derivatives, futures and options activity and sector gainers.

4 corporate actions are listed, the most recent entry being Annual General Meeting dated August 20, 2026, with a record date of August 20, 2026.

It is followed by Quarterly Result Announcement dated May 27, 2026 and Quarterly Result Announcement dated November 4, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-08-20 2026-08-20 Annual General Meeting NA 54.83%
2026-05-27 2026-05-27 Quarterly Result Announcement NA 4.56%
2025-11-04 2025-11-04 Quarterly Result Announcement NA 0.95%
2025-09-22 2025-09-22 Annual General Meeting NA -5.52%

Glen Industries Competitors Screener - Peer Stocks Comparison

Screen GLEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 447,476 36.44 61,674 12.69% 11,565 47.42
Divis Laboratories 250,363 86.51 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 186,152 85.91 13,886 20.34% 2,138 48.14
Zydus Life Science 120,798 26.32 27,658 17.64% 5,026 61.81
Cipla 111,426 33.44 29,045 2.24% 3,870 44.03
Laurus Labs 106,838 99.70 6,868 22.01% 890 58.00
Mankind Pharma 105,107 48.73 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 104,492 32.05 35,059 3.90% 4,158 69.59
Aurobindo Pharma 97,682 26.36 34,145 5.56% 3,503 54.69
Lupin 93,829 16.99 29,039 26.75% 5,356 34.02

Glen Industries Company Announcements - News & Reports Screener

Screen GLEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated August 28, 2026 and August 27, 2026.

Date Update Actions
2026-10-04 Closure of Trading Window -
2026-08-28 Announcement Under Regulation 30 (LODR)-Newspaper Publication -
2026-08-27 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-08-25 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-08-22 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-21 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-08-20 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-20 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-08-20 Announcement under Regulation 30 (LODR)-Meeting Updates -
2026-08-20 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-19 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-08-13 Regulation 32 Monitoring Agency Report -
2026-08-07 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-08-06 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-08-04 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-07-31 Outcome Of Analyst/ Institutional Investor Meeting Held On July 30 2026 & July 31 2026 -
2026-07-29 Announcement under Regulation 30 (LODR)-Meeting Updates -
2026-07-29 Annual General Meeting Of The Members Of The Company And Cut-Off Date -
2026-07-29 Newspaper Clippings - 19Th Annual General Meeting Of The Members Of The Company And Other Related Information -
2026-07-28 Shareholding Meeting Of The Company To Be Held On 20Th August 2026 For The Year Ended 2025-26 -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 2.22. Market capitalisation stands at ₹306.56 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 5, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 5 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.